- Imricor Medical Systems (IMR) partners with global meditech giant GE HealthCare to perform real-time heart ablations using GE’s MRI systems
- The two parties entered a memorandum of understanding (MOU) for an initial period of five years, automatically renewing for one year every year thereafter
- Under the MOU, cardiac ablations will be performed using Imricor’s catheters and other disposable devices on GE HealthCare’s MRI systems
- IMR is aiming to allow sites with GE HealthCare MRI systems to participate in the company’s upcoming Vision-MR Ablation of Atrial FLutter (VISABL-AFL) clinical trial in the USA, and VISABL-VT trial in Europe
- IMR shares end the week at 2.7 cents
Imricor Medical Systems (IMR) has partnered with global meditech giant GE HealthCare to perform real-time heart ablations using a mix of both companies’ technologies.
The two parties have signed a memorandum of understanding (MOU) that will see cardiac ablations performed using Imricor’s catheters and disposable devices and performed on GE HealthCare’s MRI systems
Under the terms of the MOU, GE HealthCare and Imricor will collaborate to interface Imricor’s Advantage-MR EP Recorder/Stimulator and northStar-MR 3D Mapping System with GE HealthCare’s MRI scanners
Imricor said it believed a successful collaboration would enable cardiac electrophysiology ablation procedures guided by real-time MRI.
The MOU was signed on January 24th, 2023, with an initial term of five years, and will automatically renew for one year every year unless terminated by either party.
The collaboration will involve developing hardware and software interfaces between Imricor’s devices and GE HealthCare’s systems.
IMR is aiming to allow sites with GE HealthCare MRI systems to participate in the company’s upcoming Vision-MR Ablation of Atrial FLutter (VISABL-AFL) clinical trial in the US and VISABL-VT trial in Europe.
This collaboration with GE means IMR now has collaborations with the world’s three major MRI manufacturers, including Siemens Healthineers and Phillips.
“The addition of GE HealthCare will give physicians and hospitals significantly more flexibility to use the MRI hardware of their choice when providing real-time iCMR ablations for their patients,” Imricor CEO Steve Wedan said.
“We are grateful to our existing customers who have embraced our real-time iCMR ablation technology and look forward to making the benefits of this technology even more widely available.”
IMR shares ended the week at 2.7 cents.